APG Stock Analysis: Api | NYSE
Engineering & Construction | NYSE, USA | Market Cap: 17.936m USD | 12M Return: 15.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 118M
EPS Trend: 78.7%
Qual. Beats: 0
Rev. Trend: 90.0%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 8.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
APi Group Corporation (NYSE: APG) is a global provider of fire and life safety, security, elevator and escalator, and specialty contracting services, operating through two reportable segments: Safety Services and Specialty Services. The company serves end markets such as high tech, advanced manufacturing, healthcare, fulfillment and distribution centers, and critical infrastructure, offering design, installation, inspection, service, and monitoring of life safety and building systems.
The company reached the public markets on April 29, 2020, through a merger with a special purpose acquisition company (SPAC), having previously been known as J2 Acquisition Limited before adopting its current name in October 2019. APi Group is classified within the Industrials sector and the Construction & Engineering sub-industry under the Global Industry Classification Standard (GICS).
Founded in 1926 and headquartered in New Brighton, Minnesota, APi Group has grown largely through an acquisition-based business model, consolidating regional and local safety, security, and specialty services contractors. This roll-up strategy is common in fragmented commercial services industries, where scale, regulatory compliance, and recurring service contracts create barriers to entry and support long-term customer relationships.
- Service revenue mix shift expands operating margins
- M&A consolidates fragmented fire and life safety market
- Data center and healthcare construction demand grows backlog
| Net Income: 324.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.16 > 1.0 |
| NWC/Revenue: 11.22% < 20% (prev 11.55%; Δ -0.33% < -1%) |
| CFO/TA 0.09 > 3% & CFO 782.0m > Net Income 324.0m |
| Net Debt (2.42b) to EBITDA (859.0m): 2.82 < 3 |
| Current Ratio: 1.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (435.0m) vs 12m ago 4.21% < -2% |
| Gross Margin: 29.14% > 18% (prev 30.42%; Δ -1.28% > 0.5%) |
| Asset Turnover: 95.80% > 50% (prev 88.12%; Δ 7.68% > 0%) |
| Interest Coverage Ratio: 5.87 > 6 (EBIT TTM 528.0m / Interest Expense TTM 90.0m) |
| A: 0.10 (Total Current Assets 3.02b - Total Current Liabilities 2.11b) / Total Assets 8.97b |
| B: 0.06 (Retained Earnings 574.0m / Total Assets 8.97b) |
| C: 0.06 (EBIT TTM 528.0m / Avg Total Assets 8.53b) |
| D: 0.64 (Book Value of Equity 3.49b / Total Liabilities 5.48b) |
| Altman-Z'' = 1.96 = BBB |
| DSRI: 0.99 (Receivables 2.08b/1.84b, Revenue 8.17b/7.14b) |
| GMI: 1.04 (GM 30.42% / 29.14%) |
| AQI: 0.97 (AQ_t 0.59 / AQ_t-1 0.60) |
| SGI: 1.15 (Revenue 8.17b / 7.14b) |
| TATA: -0.05 (NI 324.0m - CFO 782.0m) / TA 8.97b) |
| Beneish M = -2.91 (Cap -4..+1) = A |
As of July 18, 2026, the stock is trading at USD 40.12 with a total of 1,307,957 shares traded. Over the past week, the price has changed by -3.00%, over one month by -4.04%, over three months by -14.18% and over the past year by +15.69%.
Current recommended Stop Loss: 38.40 (which is 4.3% or 1.3 ATR below the current price).
Api has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy APG.
- StrongBuy: 6
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 52.7 | 31.4% |
P/E Forward = 20.0401
P/S = 2.1942
P/B = 5.1401
Revenue TTM = 8.17b USD
EBIT TTM = 528.0m USD
EBITDA TTM = 859.0m USD
Long Term Debt = 2.75b USD (from longTermDebt, last quarter)
Short Term Debt = 5.00m USD (from shortTermDebt, last quarter)
Debt = 3.07b USD (corrected: LT Debt 2.75b + ST Debt 5.00m) + Leases 310.0m
Net Debt = 2.42b USD (calculated: Debt 3.07b - CCE 645.0m)
Enterprise Value = 20.4b USD (17.9b + Debt 3.07b - CCE 645.0m)
Interest Coverage Ratio = 5.87 (Ebit TTM 528.0m / Interest Expense TTM 90.0m)
EV/FCF = 29.94x (Enterprise Value 20.4b / FCF TTM 680.0m)
FCF Yield = 3.34% (FCF TTM 680.0m / Enterprise Value 20.4b)
FCF Margin = 8.32% (FCF TTM 680.0m / Revenue TTM 8.17b)
Net Margin = 3.96% (Net Income TTM 324.0m / Revenue TTM 8.17b)
Gross Margin = 29.14% ((Revenue TTM 8.17b - Cost of Revenue TTM 5.79b) / Revenue TTM)
Gross Margin QoQ = 28.10% (prev 29.19%)
Tobins Q-Ratio = 2.27 (Enterprise Value 20.4b / Total Assets 8.97b)
Interest Expense / Debt = 2.93% (Interest Expense 90.0m / Debt 3.07b)
Taxrate = 26.03% (114.0m / 438.0m)
NOPAT = 390.6m (EBIT 528.0m * (1 - 26.03%))
Current Ratio = 1.44 (Total Current Assets 3.02b / Total Current Liabilities 2.11b)
Debt / Equity = 0.88 (Debt 3.07b / totalStockholderEquity, last quarter 3.49b)
Debt / EBITDA = 2.82 (Net Debt 2.42b / EBITDA 859.0m)
Debt / FCF = 3.57 (Net Debt 2.42b / FCF TTM 680.0m)
Total Stockholder Equity = 3.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.80% (Net Income 324.0m / Total Assets 8.97b)
RoE = 9.71% (Net Income TTM 324.0m / Total Stockholder Equity 3.34b)
RoCE = 8.67% (EBIT 528.0m / Capital Employed (Equity 3.34b + L.T.Debt 2.75b))
RoIC = 6.05% (NOPAT 390.6m / Invested Capital 6.46b)
WACC = 8.94% (E(17.9b)/V(21.0b) * Re(10.10%) + D(3.07b)/V(21.0b) * Rd(2.93%) * (1-Tc(0.26)))
Discount Rate = 10.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 47.31 | Cagr: 9.80%
[DCF] Terminal Value 75.77% ; FCFF base≈648.4m ; Y1≈731.6m ; Y5≈1.03b
[DCF] Fair Price = 27.07 (EV 14.2b - Net Debt 2.42b = Equity 11.7b / Shares 433.2m; r=8.94% [WACC]; 5y FCF grow 13.14% → 2.50% )
EPS Correlation: 78.74 | EPS CAGR: 29.24% | SUE: 0.24 | # QB: 0
Revenue Correlation: 89.97 | Revenue CAGR: 6.37% | SUE: 1.08 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.44 | Chg30d=-0.59% | Revisions=-17% | Analysts=11
EPS next Quarter (2026-09-30): EPS=0.46 | Chg30d=-0.26% | Revisions=+40% | Analysts=11
EPS current Year (2026-12-31): EPS=1.14 | Chg30d=-5.45% | Revisions=-25% | GrowthEPS=+264.9% | GrowthRev=+10.2%
EPS next Year (2027-12-31): EPS=1.95 | Chg30d=+0.23% | Revisions=+29% | GrowthEPS=+14.5% | GrowthRev=+6.7%
[Analyst] Revisions Ratio: +15% (up=6, down=4)